Clinical Trial Update: Phase II Safety and Efficacy Study of 18FDOPA PET-CT in Children With Hyperinsulinemic Hypoglycemia [Phase 2]

View source ↗

Summary

Phase II study assessing safety and efficacy of 18FDOPA PET-CT imaging in children with congenital hyperinsulinism and persistent hyperinsulinemic hypoglycemia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hyperinsulinism
• Persistent Hyperinsulinemic Hypoglycemia of Infancy

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Congenital Hyperinsulinism (CHI), Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI) | Phase 2 | Status: COMPLETED | Results posted: 2021-10-15